Atlas Trials

the"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs

Clinical trial NCT02603003 · COMPLETED

Trial details

NCT number
NCT02603003
Sponsor
Shanghai University of Traditional Chinese Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer(NSCLC)
Start date
2015-06-01
Primary completion
2019-09-01
Enrollment
218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.